Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
936.92
878.57
737.43
554.80
408.40
565.02
546.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
936.92
878.57
737.43
554.80
408.40
565.02
546.52
Raw Material Cost
0.00
0.00
0.00
0.00
114.89
141.24
129.41
Purchase of Finished goods
0.00
0.00
0.00
0.10
0.30
1.49
1.45
(Increase) / Decrease In Stocks
0.01
0.00
0.00
0.13
1.27
-3.84
-0.28
Employee Cost
148.37
138.95
120.78
104.30
83.99
103.42
97.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
565.21
540.31
459.93
341.54
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
71.54
66.61
62.77
41.28
172.76
261.25
254.85
Total Expenditure (Excl Depreciation)
785.13
745.87
643.48
487.35
373.21
503.56
482.71
Operating Profit (PBDIT) excl Other Income
151.79
132.70
93.95
67.45
35.19
61.46
63.81
Other Income
32.99
7.35
7.34
3.90
3.54
4.60
4.00
Operating Profit (PBDIT)
184.78
140.05
101.29
71.35
38.73
66.06
67.81
Interest
31.94
31.29
19.68
11.98
12.93
12.80
11.00
Exceptional Items
0.00
0.00
0.00
0.00
3.23
0.00
0.00
Gross Profit (PBDT)
152.84
108.76
81.61
59.37
29.03
53.26
56.81
Depreciation
45.16
40.32
31.00
22.19
21.51
22.63
20.07
Profit Before Tax
107.67
68.45
50.61
37.18
7.53
30.63
36.74
Tax
25.49
19.31
12.59
5.78
1.37
11.17
16.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.18
49.14
38.01
31.40
6.16
19.46
20.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.18
49.14
38.01
31.40
6.16
19.46
20.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.45
0.00
0.59
0.41
0.33
0.33
0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.63
49.14
38.60
31.81
6.49
19.79
20.49
Equity Capital
13.76
13.59
13.41
13.24
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
1.0
10.0
10.0
10.0
Reserves
755.43
366.78
0.00
279.26
240.57
234.02
214.55
Earnings per share (EPS)
6.01
3.62
2.88
2.4
4.9
14.95
15.48
Diluted Earnings per share
5.31
3.53
2.79
2.29
4.9
14.95
15.48
Operating Profit Margin (Excl OI)
16.2%
15.1%
12.74%
12.16%
8.62%
10.88%
11.68%
Gross Profit Margin
16.31%
12.38%
11.07%
10.7%
7.11%
9.43%
10.39%
PAT Margin
8.77%
5.59%
5.15%
5.66%
1.51%
3.44%
3.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.64% vs 19.14% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 68.15% vs 27.31% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 14.39% vs 41.25% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 2.08% vs 58.99% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Artemis Medicare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
936.92
0
936.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
936.92
0
936.92
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.01
0
0.01
Employee Cost
148.37
0
148.37
Power Cost
0.00
0
0.00
Manufacturing Expenses
565.21
0
565.21
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
71.54
0.00
71.54
Total Expenditure (Excl Depreciation)
785.13
0
785.13
Operating Profit (PBDIT) excl Other Income
151.79
0.00
151.79
Other Income
32.99
0
32.99
Operating Profit (PBDIT)
184.78
0
184.78
Interest
31.94
0
31.94
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
152.84
0
152.84
Depreciation
45.16
0
45.16
Profit Before Tax
107.67
0
107.67
Tax
25.49
0
25.49
Provisions and contingencies
0.00
0
0.00
Profit After Tax
82.18
0
82.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
82.18
0
82.18
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.45
0
0.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.63
0
82.63
Equity Capital
13.76
0
13.76
Face Value
1.00
0
0.00
Reserves
755.43
0
755.43
Earnings per share (EPS)
6.01
0
6.01
Diluted Earnings per share
5.31
0
5.31
Operating Profit Margin (Excl OI)
16.20%
0%
0.00
16.20%
Gross Profit Margin
16.31%
0%
0.00
16.31%
PAT Margin
8.77%
0%
0.00
8.77%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 936.92 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.64% vs 19.14% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 82.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 68.15% vs 27.31% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.79 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.39% vs 41.25% in Mar 2024
Annual - Interest
Interest 31.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.08% vs 58.99% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.20%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






